| |
| |
|
| Insider
Information: |
Lamb Peter |
| Relationship: |
EVP, Scientific Strate... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
410,958 |
|
|
Indirect Shares
|
17,105 |
|
|
| Direct
Value |
$8,913,679 |
|
|
|
Indirect Value
|
$371,007 |
|
|
| Total
Shares |
428,063 |
|
|
| Total
Value |
$9,284,686 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
EVP, Scientific Strate... |
2022-12-15 |
410,958 |
2022-12-15 |
17,105 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
112 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2022-02-15 |
4 |
D |
$18.59 |
$375,090 |
D/D |
(20,177) |
342,995 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-02-03 |
4 |
D |
$22.56 |
$451,132 |
D/D |
(19,997) |
343,790 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2020-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
213,879 |
347,457 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2020-12-18 |
4 |
OE |
$1.70 |
$110,500 |
D/D |
65,000 |
348,124 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-01-04 |
4 |
OE |
$1.70 |
$110,500 |
D/D |
65,000 |
348,124 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-02-01 |
4 |
OE |
$1.70 |
$110,500 |
D/D |
65,000 |
348,124 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-11-15 |
4 |
D |
$18.10 |
$1,125,150 |
D/D |
(62,163) |
349,077 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-12-15 |
4 |
AS |
$17.44 |
$828,400 |
D/D |
(47,500) |
363,172 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-12-15 |
4 |
D |
$17.00 |
$78,982 |
D/D |
(4,646) |
363,172 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
80,663 |
363,787 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
18,741 |
367,818 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
49,395 |
389,467 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-04-01 |
4 |
AS |
$22.96 |
$1,377,600 |
D/D |
(60,000) |
389,467 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-06-17 |
4 |
AS |
$22.18 |
$1,330,800 |
D/D |
(60,000) |
389,467 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-07-15 |
4 |
AS |
$17.47 |
$1,048,200 |
D/D |
(60,000) |
389,467 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-08-16 |
4 |
AS |
$18.44 |
$1,014,200 |
D/D |
(55,000) |
389,467 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-09-15 |
4 |
AS |
$20.46 |
$971,850 |
D/D |
(47,500) |
389,467 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2022-05-15 |
4 |
D |
$20.08 |
$122,950 |
D/D |
(6,123) |
396,362 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2022-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
59,490 |
402,485 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-03-01 |
4 |
OE |
$1.70 |
$110,500 |
D/D |
65,000 |
405,072 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-12-15 |
4 |
OE |
$6.21 |
$294,975 |
D/D |
47,500 |
410,672 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2022-11-15 |
4 |
D |
$16.71 |
$119,928 |
D/D |
(7,177) |
410,958 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2022-12-15 |
4 |
AS |
$15.88 |
$317,600 |
D/D |
(20,000) |
410,958 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-09-30 |
4 |
D |
$20.63 |
$148,062 |
D/D |
(7,177) |
411,240 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-10-15 |
4 |
AS |
$21.92 |
$1,041,200 |
D/D |
(47,500) |
411,240 |
0 |
% |
|
112 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
